Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.
Event: ESC Congress 2021 - The Digital Experience
Topic: Antiarrhythmic Pharmacotherapy
Session: Pharmacology and pharmacotherapy e-posters
